Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Ligand Nabs $2M From Merck
|
Luke Timmerman |
11/19/09 |
San Diego
|
|
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer
|
Luke Timmerman |
11/05/09 |
Boston
|
|
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat
|
Luke Timmerman |
10/28/09 |
San Diego
|
|
Why is Pharma Betting So Big on Innovation in Boston?
|
Luke Timmerman |
10/27/09 |
Boston
|
|
Isilon, Forged in Fire of Last Recession, Looks to Expand Its Data Storage Business in This One
|
Gregory T. Huang |
10/22/09 |
Seattle
|
|
Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029
|
Luke Timmerman |
10/21/09 |
Seattle
|
|
See You Tonight at Seattle Life Sciences 2029
|
Luke Timmerman |
10/19/09 |
Seattle
|
|
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent
|
Luke Timmerman |
10/09/09 |
National
|
|
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles
|
Luke Timmerman |
10/06/09 |
Seattle
|
|
Abimab Snags $8.2M in Equity
|
Luke Timmerman |
10/06/09 |
Boston
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Swine Flu Could Benefit Some Biomedical Companies, Local Biotechs Are Looking Healthier, Arena Happy With Obesity Drug Results, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/24/09 |
San Diego
|
|
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs
|
Luke Timmerman |
09/18/09 |
San Diego
|
|
How Biotechs Can Stand Out in the Competition for a Big Pharma Partnership
|
Peppi Prasit |
09/17/09 |
San Diego
|
|
Autism Gets a Boost: Seaside Therapeutics Raises $30M To Develop First Drugs That Might Work
|
Luke Timmerman |
09/17/09 |
Boston
|
|
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/03/09 |
Seattle
|
|
Gloucester Gears Up for FDA Panel Vote on Lymphoma Drug
|
Luke Timmerman |
09/02/09 |
Boston
|
|
The Rosetta Diaspora: Genetics Talent Stays Close to Home After Merck Shuts Down in Seattle
|
Luke Timmerman |
09/02/09 |
Seattle
|
|
San Diego’s Palkion Chases Amgen’s Big Market, Joins Race to Develop Oral Anemia Drug
|
Luke Timmerman |
09/01/09 |
San Diego
|
|
Microsoft’s Summer of Love: A Roundup of the Company’s Hottest Deals and Other News
|
Eric Hal Schwartz |
08/31/09 |
Seattle
|
|
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Resolvyx Nails Dry Eye Trial, Gloucester Pulls in $29M, Shire Beefs Up Mass Presence, & Other Boston-Area Life Sciences News
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
|
Luke Timmerman |
08/25/09 |
San Diego
|
|
Ligand Gets Neurogen for $11M
|
Bruce V. Bigelow |
08/24/09 |
San Diego
|
|
VC Rick Klausner on the Future of Vaccines, and Why Dendreon is Only Scratching the Surface
|
Luke Timmerman |
08/19/09 |
Seattle
|
|
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News
|
Gregory T. Huang |
08/11/09 |
Seattle
|
|
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
Page 1 of
5 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
